Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search a test
Simple search

Simple search

*
(*) mandatory field


 

151 Result(s)

Result(s)sorted by
Speciality(ies)/objective(s)
(123)
(11)
(4)
(49)
(16)
(29)
(29)
(1)
Technique(s)
(44)
(5)
(20)
(1)
Purpose(s)
(7)
(4)
(128)
(2)
(1)
(1)
(19)
Quality management
(46)
(93)
Country(ies)
(4)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(17)
(40)
(1)
(2)
(1)
(1)
(15)
(1)
(1)
(2)
(1)
(3)
(4)
(2)
(1)
(2)
(24)
(2)
(1)
(1)
(12)
RESET
Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • Accreditation
    • Biochemical diagnosis of congenital adrenal hyperplasia (21-hydroxylase, 11-hydroxylase, 3-beta-hydroxysteroid dehydrogenase)
    • Laboratoire Cerba
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • Labor Lademannbogen
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, CYP17A1, HSD3B2 genes)
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Medizinisches Versorgungszentrum Humane Genetik
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: sequencing / MLPA; CYP11B1, HSD3B2, POR genes: sequencing)
    • Universitätsklinikum Regensburg
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : Sanger sequencing, MLPA based techniques
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, and HSD3B2 genes)
    • Medizinische Universität Innsbruck
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Risk assessment
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing, PCR based techniques, MLPA based techniques
    • More information
    • AUSTRIA
    • TIROL
    • INNSBRUCK
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of Congenital adrenal hyperplasia (CYP21 gene)
    • University Hospital of Antwerp - UZA- Centrum Medische Genetica - CMG
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN-EDEGEM
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (CYP21A2 gene: Diagnosis available by NIPD (non-invasive pre-natal diagnostic) / post-natal targetted mutation analysis)
    • St Mary's Hospital
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
    • Mitteldeutscher Praxisverbund Humangenetik
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes)
    • Zentrum für Humangenetik Mannheim
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Baden-Württemberg
    • MANNHEIM
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Medizinische Versorgungszentrum Dr.Stein + Kollegen
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÖNCHENGLADBACH
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (DAX1 analysis)
    • International Centre for Life
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CY11B1, CYP21A2, HSD3B2 genes)
    • Praxis für Humangenetik Freiburg
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Accreditation
    • Biochemical diagnosis of Congenital adrenal hyperplasia (Analytes: 17 hydroxyprogesterone, renin, aldosterone, DHEAS & urine steroid profiles)
    • Biochemistry services - UCL Hospitals Foundation NHS Trust
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1genes)
    • Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, HSD3B2 genes)
    • Centogene AG
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
    • Diagenom GmbH
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Institut für Humangenetik am Universitätsklinikum Heidelberg
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (CYP21A2 gene)
    • Radboudumc - Radboud universitair medisch centrum
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Paxis und Labor Dr. med Karl Mehnert
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Bayern
    • NEU-ULM
    • Accreditation
    • Neonatal screening : Biochemical diagnosis of congenital adrenal hyperplasia
    • Universitätsklinikum Carl Gustav Carus an der TU Dresden
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Institut für Medizinische & Molekulare Diagnostik AG
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • ZÜRICH
    • Accreditation
    • Neonatal screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (17-OH-progesterone: GSP (Delfia method), bloodspots)
    • Provinciaal Centrum voor opsporing van Metabole Aandoeningen (PCMA) - Antwerpen
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (CYP21A2 gene)
    • Birmingham Women's NHS Foundation Trust
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Medizinisch Genetisches Zentrum München
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 and HSD3B2 genes)
    • GenteQ GmbH
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: sequencing / MLPA)
    • MVZ Labor Dr. Reising-Ackermann und Kollegen
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Labor PD Dr. Volkmann und Kollegen
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Baden-Württemberg
    • KARLSRUHE
    • Accreditation
    • Neonatal screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (17-OH-progesterone: ELISA, bloodspots)
    • CHU Sart Tilman - Liège
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • BELGIUM
    • LIEGE
    • LIEGE
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene): analysis of the entire coding region
    • Instituto de Biologia Molecular e Celular
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CY11B1, CYP21A2, HSD3B2 genes)
    • MVZ Fenner & Krasemann
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Neonatal screening of congenital adrenal hyperplasia
    • CHRU de Besançon - Hôpital Saint-Jacques
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • FRANCHE-COMTE
    • BESANÇON
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: APEX and MPLA)
    • Asper Biotech Ltd.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, POR genes: sequencing)
    • Pränatalmedizin München
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of Sex Determination For X-Linked Conditions For Disorders That Manifest Significantly Different In One Sex Compared To The Other by Targetted Mutation and Copy Number Analysis (Genes: AMELX, AMELY, SRY)
    • Liverpool Women's NHS Foundation Trust
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • UNITED KINGDOM
    • Merseyside
    • LIVERPOOL
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (NR0B1 gene: Sequencing of the entire coding region of gene (s) / Testing for known mutations in family members)
    • International Centre for Life
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Molecular Diagnosis of Male Infertility Due To Y Chromosome Deletions (DDX3Y, DAZ1, DAZ2, DAZ3, USP9Y genes: targeted mutation analysis)
    • Salisbury District Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Deletion / Duplication analysis
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Reference Laboratory Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • L'HOSPITALET DE LLOBREGAT
    • Accreditation
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (MLPA for dosage/genomic rearrangements plus analysis of common point mutations, CYP21A2 gene)
    • St James's University Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • Technical procedure(s) : MLPA based techniques
    • More information
    • UNITED KINGDOM
    • West Yorkshire
    • LEEDS
    • Accreditation
    • Preimplantation genetic diagnosis of the congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Sistemas Genómicos S.L.
    • Purpose(s) : Pre-implantation diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Accreditation
    • Biochemical diagnosis of Congenital Adrenal Hyperplasia, due to 21-hydroxylase deficiency, classic form (Analyte: 17-hydroxyprogesterone)
    • Southampton General Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • UNITED KINGDOM
    • Hampshire
    • SOUTHAMPTON
    • Accreditation
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2, HSD3B2 genes)
    • IFLb Laboratoriumsmedizin Berlin GmbH
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular Diagnosis of Male Infertility Due To Y Chromosome Deletions (DDX3Y, DAZ1, DAZ2, DAZ3, USP9Y genes: targeted mutation analysis / Testing for known mutations in family members)
    • St James's University Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Deletion / Duplication analysis
    • More information
    • UNITED KINGDOM
    • West Yorkshire
    • LEEDS
    • Accreditation
    • Newborn screening : Biochemical diagnosis of congenital adrenal hyperplasia (Immunoassay, tandem mass spectrometry, steroid profile by LC-MSMS)
    • Screening-Labor Hannover
    • Purpose(s) : Post-natal diagnosis, Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay, Protein expression
    • Technical procedure(s) : Immunohistochemistry
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU Paris - Hôpital Robert Debré
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Lyon HCL - GH Est
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • RHONE-ALPES
    • BRON
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Caen - Hôpital de la Côte de Nacre
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • BASSE-NORMANDIE
    • CAEN
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Grenoble site Nord - Institut de biologie et de pathologie
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • RHONE-ALPES
    • GRENOBLE
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU d'Angers
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • ANGERS
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing, MLPA based techniques
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of 21-hydroxylase deficiency (CYP21A2 gene)
    • Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A1 gene)
    • Laboratorio Genoma
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2 genes)
    • Laborärztlich-humangenetische Partnerschaft Eiben - Glaubitz
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • ESSEN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • Ospedale Regionale per le Microcitemie
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • SARDEGNA
    • CAGLIARI
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, CYP17A1, HSD3B2 genes)
    • CHUS - Complejo Hospitalario Universitario de Santiago
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Galicia
    • SANTIAGO DE COMPOSTELA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • IRCCS Ospedale San Raffaele
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • PIEMONTE
    • TORINO
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene): analysis of the entire coding region and UTR 5' and deletion/duplication analysis.
    • Faculdade de Medicina da Universidade do Porto
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP17A1, CYP21A2, CYP11B1, HSD3B2 genes)
    • Praxis Dres. Gencik
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Klinikum Stuttgart - Standort Olgahospital
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene: copy number estimation and complete sequencing)
    • Rigshospitalet
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • More information
    • DENMARK
    • Hovedstaden
    • COPENHAGEN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1 and CYP17A1 genes)
    • INGEMM - Instituto de Genética Médica y Molecular (IdiPAZ)
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Full mutation analysis via sequencing for Congenital Adrenal Hyperplasia (CYP21A2 gene 6p31.23)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, CYP11B1, HSD3B2 genes)
    • Centro de Diagnóstico Biomédico - CDB
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (mutations in CYP21A2 gene)
    • Hospital Universitario Central de Asturias
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular diagnosis of congenital adrenal hyperplasia by allele-specific amplification (CYP21A2 gene)
    • Semmelweis University Hospital - 2nd Department of Paediatrics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • HUNGARY
    • Közép-Magyarország
    • BUDAPEST
    • Neonatal screening of congenital adrenal hyperplasia
    • CHRU de Lille - Centre de Biologie Pathologie Génétique
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Molecular diagnosis of congenital adrenal hyperplasia 11-beta-hydroxylase, 17-alpha-hydroxylase, 17-beta-hydroxylase, 21-beta-hydroxylase (HSD3B2, CYP11B1, CYP17A1, HSD17B3, CYP21A2 genes)
    • Karolinska University Hospital - Clinical Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SWEDEN
    • Stockholms läns landsting
    • STOCKHOLM
    • Molecular diagnosis of congenital adrenal hyperplasia (STAR gene)
    • Karolinska University Hospital - Clinical Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SWEDEN
    • Stockholms läns landsting
    • STOCKHOLM
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes)
    • Institut für Klinische Genetik Bonn
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BONN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • University Medical Centre Ljubljana
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SLOVENIA
    • SLOVENIA
    • LJUBLJANA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Oslo University Hospital, Ullevaal
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • NORWAY
    • Østlandet
    • OSLO
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP17A1, CYP21A2 genes: sequencing/MLPA)
    • bio.logis Zentrum für Humangenetik
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Molecular diagnosis of congenital adrenal hyperplasia (CY11B1, CYP17A1, CYP21A2, HSD3B2 genes: sequencing / MLPA)
    • Pränatalzentrum Hamburg und Humangenetik
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : Sanger sequencing, MLPA based techniques
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Molecular diagnosis of congenital adrenal hyperplasia. CYP21A2 and CYP11B genes.
    • Genetaq
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnostics of congenital adrenal hyperplasia (CYP21A2 gene)
    • Instytut "Pomnik-Centrum Zdrowia Dziecka"
    • Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of the congenital adrenal hyperplasia (CYP21A2 gene)
    • Sistemas Genómicos S.L.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of congenital adrenal hyperplasia. HSD3B2 gene.
    • Genetaq
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of congenital adrenal hyperplasia
    • Maribor general hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SLOVENIA
    • SLOVENIA
    • MARIBOR
    • Molecular diagnosis of congenital adrenal hyperplasia (CY11B1 and HSD3B2 genes: sequencing, CYP21A2 gene: sequencing/ MLPA)
    • Molekulargenetisches Labor der Gemeinschaftspraxis
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • CHU Paris Centre - Hôpital Cochin
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CHU de Lyon HCL - GH Est
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing, PCR based techniques, MLPA based techniques
    • More information
    • FRANCE
    • RHONE-ALPES
    • BRON
    • Molecular diagnosis of congenital adrenal hyperplasia (entire coding sequence of CYP11B1, CYP17A1, CYP21A2 and HSD3B2 genes)
    • Lorgen G.P.
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • More information
    • SPAIN
    • Andalucía
    • ARMILLA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Hospital de la Santa Creu i Sant Pau
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia (Analysis of mutations in CYP21A2 coding region)
    • NZOZ GENOMED
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Preimplantation genetic diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Reprogenetics Spain S.A.
    • Purpose(s) : Pre-implantation diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (sequencing and MLPA of CYP21A2 gene)
    • DNA Data
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, classic form (CYP21A2 gene)
    • Genetaq
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Hospital Materno Infantil Gregorio Marañón
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing, PCR based techniques
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • IMEGEN - Instituto de Medicina Genómica
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Gemeinschaftspraxis Dr. Susanne Ebner und Dr. Susanne Markus
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2, HSD3B2 genes: sequencing / MLPA)
    • Gemeinschaftspraxis für Humangenetik
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region
    • Technical procedure(s) : Sanger sequencing
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Biotecnologie Avanzate Srl
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene): Target mutation analysis - panel of mutations (P30L, 659A>G, 8bp DEL, I172N, e6 cluster, V281L, F306+t, Q318X, R356W, P453S) and sequence analysis of the entire coding region and deletion/duplication analysis by MLPA
    • CGC Genetics / Centro de Genética Clínica
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : NGS sequencing (except WES), MLPA based techniques
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Preimplantation genetic diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CME Barcelona
    • Purpose(s) : Pre-implantation diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Praxis für medizinische Genetik
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • MVZ Humangenetik Ulm
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Molecular diagnosis of Adrenogenital syndrome (CYP11B1, CYP17A1, CYP21A2, and HSD3B2 genes)
    • Praxis für Humangenetik
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • CIBIR - Centro de Investigación Biomédica de La Rioja
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of congenital adrenal hyperplasia (Analysis of mutations in CYP21A2 coding region)
    • MEDGEN
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Hospital Universitari General Vall d'Hebron
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Azienda Ospedaliera Universitaria Integrata di Verona - Ospedale Borgo Roma
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • VENETO
    • VERONA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene / MLPA, mutations panel)
    • Centro Inmunológico de Alicante (CIALAB)
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : NGS sequencing (except WES), MLPA based techniques
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene / sequencing)
    • Universidad de Salamanca. Facultad de Medicina
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Castilla - León
    • SALAMANCA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene / sequencing mutations)
    • Instituto Bernabeu Biotech
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • ALICANTE
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • ViennaLab Diagnostics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Allgemeines Krankenhaus der Stadt Wien
    • Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
    • Technical procedure(s) : Sanger sequencing, MLPA based techniques
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular Diagnosis of Congenital Adrenal Hyperplasia (sequence analysis and MLPA of CYP21A2 coding regions)
    • Alberta Children's Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • CANADA
    • Alberta
    • CALGARY
    • Full mutation analysis for Congenital Adrenal Hyperplasia via MLPA (CYP21A2 gene 6p31.23)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : MLPA based techniques
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of known mutation for Congenital Adrenal Hyperplasia (CYP21A2 gene 6p31.23)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Targeted mutation analysis
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • DNA storage/extraction of CYP21A2 for Congenital Adrenal Hyperplasia (CYP21A2 gene 6p31.23)
    • The Cyprus Institute of Neurology and Genetics
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Dijon - Plateau technique de Biologie
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • BOURGOGNE
    • DIJON
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Strasbourg - Hôpital Civil
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • ALSACE
    • STRASBOURG
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Bordeaux-GH Sud - Hôpital Haut-Lévêque
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • AQUITAINE
    • PESSAC
    • Neonatal screening of congenital adrenal hyperplasia
    • Centre régional de dépistage néonatal
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Nantes - Hôpital femme-enfant-adolescent
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • NANTES
    • Diagnostics and monitoring of steroid related disorders by gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry (steroid metabolomics)
    • Kinderklinik des UKGM am Standort Gießen
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • GERMANY
    • Hessen
    • GIEßEN
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Azienda Ospedaliera Universitaria "Federico II"
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • Azienda Ospedaliera Ospedali Riuniti "Villa Sofia-Cervello" - Presidio Cervello
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • SICILIA
    • PALERMO
    • Biochemical diagnosis of congenital adrenal hyperplasia
    • Mater Misericordiae Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • IRELAND
    • County Dublin
    • DUBLIN
    • Molecular diagnosis of congenital adrenal hyperplasia
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Biochemical diagnosis of congenital adrenal hyperplasia
    • Spitalul de Pediatrie Copii Cluj
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ
    • Molecular and biochemical diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 11-betahydroxylase deficiency
    • U.M.F. Iuliu Hatieganu Cluj
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics, Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21 gene)
    • Policlinico S. Orsola-Malpighi - Area S. Orsola
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • BOLOGNA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Praxis Dr. med. Ulrike Beudt
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Postnatal and prenatal molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • University hospital Brno
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • CZECH REPUBLIC
    • South Moravia
    • BRNO
    • Molecular diagnosis of congenital adrenal hyperplasia
    • Acibadem healthcare group
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Ospedale Niguarda Ca' Granda
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Biochemical diagnosis of congenital adrenal hyperplasia
    • Ospedale dei Bambini ''Vittore Buzzi"
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Newborn screening : Biochemical diagnosis of congenital adrenal hyperplasia
    • Dietmar-Hopp-Stoffwechselzentrum
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Molecular diagnosis of male infertility with normal virilisation due to acquired testicular defect associated with mycoplasma infection
    • BIOAESIS
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • MARCHE
    • JESI
    • Molecular diagnosis of Congenital Adrenal Hyperplasia (CYP21A2, Linkage analysis, PGD)
    • Shaare Zedek Medical Center
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Biochemical diagnosis of Congenital Adrenal Hyperplasia
    • Central Manchester University Hospitals - Clinical Sciences Building (CSB3)
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Molecular diagnosis of congenital adrenal hyperplasia (complete CYP21A2 gene sequencing)
    • Université Saint-Joseph
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • LEBANON
    • Beyrouth
    • BEIRUT
    • Molecular diagnosis of congenital adrenal hyperplasia. CYP17A1 gene
    • Vall d'Hebron Institut de Recerca VHIR
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Biochemical diagnosis of Congenital Adrenal Hyperplasia, due to 21-hydroxylase deficiency, classic form (Analyte: 17-hydroxyprogesterone)
    • Royal Group of Hospitals Belfast
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • UNITED KINGDOM
    • Antrim and Newtownabbey
    • BELFAST
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene: allele-specific PCR and sequencing)
    • "Aghia Sophia" Children's Hospital
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : PCR based techniques
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • University of Eastern Finland
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • FINLAND
    • Finland
    • KUOPIO
    • Neonatal screening of congenital adrenal hyperplasia
    • CHU de Reims - American Memorial Hospital
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Newborn screening: Biochemical diagnosis of Congenital Adrenal Hyperplasia (Analyte: 17-Hydroxyprogesterone)
    • RIVM - Rijksinstituut voor Volksgezondheid en Milieu
    • Purpose(s) : Newborn screening
    • Specialty(ies) : Biochemical genetics
    • Objective(s) : Analyte / Enzyme assay
    • More information
    • NETHERLANDS
    • Utrecht
    • BILTHOVEN
    • Preimplantation genetic diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Igenomix Spain
    • Purpose(s) : Pre-implantation diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene)
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Prenatal and postnatal molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CYP21A2 gene: nested PCR, RT-PCR, MLPA, SnaPshot, fragmentation and sequencing)
    • University Hospital Bratislava - Stare mesto
    • Purpose(s) : Antenatal diagnosis, Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Technical procedure(s) : PCR based techniques, MLPA based techniques
    • More information
    • SLOVAKIA
    • Bratislavsky kraj
    • BRATISLAVA
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP11B1, CYP21A2, CYP17A1, HSD3B2 genes: sequencing))
    • ATG GenMed GmbH
    • Purpose(s) : Post-natal diagnosis
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of Congenital Adrenal Hyperplasia
    • Children's University Hospital Zagreb
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • More information
    • CROATIA
    • CROATIA
    • ZAGREB
    • Molecular diagnosis of male infertility due to Y chromosome deletions (AZF)
    • Institut National d'Hygiène
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Deletion / Duplication analysis
    • More information
    • MOROCCO
    • Rabat
    • RABAT
    • Molecular diagnosis of congenital adrenal hyperplasia (CYP21A2 gene)
    • Presidio Ospedaliero "Madonna delle Grazie" - Azienda Sanitaria di Matera (ASM)
    • Purpose(s) : Somatic genetics
    • Specialty(ies) : Molecular genetics
    • More information
    • ITALY
    • BASILICATA
    • MATERA
    • Mutation screening in Congenital Adrenal Hyperplasia
    • 2nd Department of Internal Medicine, Semmelweis University
    • Purpose(s) : Post-natal diagnosis
    • Specialty(ies) : Molecular genetics
    • Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
    • Technical procedure(s) : Sanger sequencing
    • More information
    • HUNGARY
    • Közép-Magyarország
    • BUDAPEST